Additionally, our RL-based system delivers continuous and real-time insulin dosage recommendation for patients with T2D who are receiving subcutaneous insulin injection, combining optimal policies for clinical decision-making and the mimicking of experienced physicians29. This evidence concerns the gene INS and type 2 diabetes mellitus.